178 related articles for article (PubMed ID: 1568399)
1. Role of CEA, TPA, and Ca 19-9 in the early detection of localized and diffuse recurrent rectal cancer.
Barillari P; Bolognese A; Chirletti P; Cardi M; Sammartino P; Stipa V
Dis Colon Rectum; 1992 May; 35(5):471-6. PubMed ID: 1568399
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal cancer follow-up: the effectiveness of sequential CEA, TPA and Ca 19-9 evaluation in the early diagnosis of recurrences.
Barillari P; Sammartino P; Cardi M; Ricci M; Gozzo P; Cesareo S; Cerasi A
Aust N Z J Surg; 1991 Sep; 61(9):675-80. PubMed ID: 1877936
[TBL] [Abstract][Full Text] [Related]
3. The role of CEA, TPA and CA 19-9 in the early detection of recurrent colorectal cancer.
Barillari P; Ramacciato G; de Angelis R; Gozzo P; Aurello P; Indinnimeo M; Valabrega S; D'Angelo F; Fegiz G
Int J Colorectal Dis; 1989 Dec; 4(4):230-3. PubMed ID: 2693562
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery.
Fucini C; Tommasi SM; Rosi S; Malatantis G; Cardona G; Panichi S; Bettini U
Dis Colon Rectum; 1987 Apr; 30(4):273-7. PubMed ID: 3470172
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
[TBL] [Abstract][Full Text] [Related]
6. CA 15-3 in human breast cancer. Comparison with tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).
Caponigro F; Iaffaioli RV; Pagliarulo C; De Placido S; Frasci G; Ungaro B; Matano E; Bianco AR
Int J Biol Markers; 1990; 5(2):73-6. PubMed ID: 2283480
[TBL] [Abstract][Full Text] [Related]
7. Individual cutoff levels of carcinoembryonic antigen and CA 242 indicate recurrence of colorectal cancer with high sensitivity.
Engarås B
Dis Colon Rectum; 2003 Mar; 46(3):313-21. PubMed ID: 12626905
[TBL] [Abstract][Full Text] [Related]
8. Differences in serum tumor markers between colon and rectal cancer. Comparison of CA 242 and carcinoembryonic antigen.
Carpelan-Holmström MA; Haglund CH; Roberts PJ
Dis Colon Rectum; 1996 Jul; 39(7):799-805. PubMed ID: 8674374
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
[TBL] [Abstract][Full Text] [Related]
10. The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigen.
Safi F; Kohler I; Röttinger E; Beger H
Cancer; 1991 Aug; 68(3):574-82. PubMed ID: 2065278
[TBL] [Abstract][Full Text] [Related]
11. A novel method for monitoring high-risk breast cancer with tumor markers: CA 15.3 compared to CEA and TPA.
Sölétormos G; Nielsen D; Schiøler V; Skovsgaard T; Winkel P; Mouridsen HT; Dombernowsky P
Ann Oncol; 1993 Dec; 4(10):861-9. PubMed ID: 8117606
[TBL] [Abstract][Full Text] [Related]
12. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
[TBL] [Abstract][Full Text] [Related]
13. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness of quarterly assessment of CEA, TPA and GICA serum levels in gastric and colorectal carcinomas: Prospective study of 174 patients undergoing radical surgery].
Barillari P; Ricci M; Broglia S; Manetti G; Cerasi A; Cesareo S; Calcaterra D; Cioè I; Caronna R; Sammartino P
Minerva Chir; 1994 Oct; 49(10):953-61. PubMed ID: 7808670
[TBL] [Abstract][Full Text] [Related]
15. Serum CA 242 and CEA detect different patients with recurrent colorectal cancer.
Carpelan-Holmström MA; Haglund CH; Järvinen HJ; Roberts PJ
Anticancer Res; 1996; 16(2):981-6. PubMed ID: 8687164
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer.
Marrelli D; Pinto E; De Stefano A; Farnetani M; Garosi L; Roviello F
Am J Surg; 2001 Jan; 181(1):16-9. PubMed ID: 11248169
[TBL] [Abstract][Full Text] [Related]
17. CEA and CA 15-3 in primary and recurrent breast cancer.
O'Dwyer PJ; Duffy MJ; O'Sullivan F; McDermott E; Losty P; O'Higgins NJ
World J Surg; 1990; 14(5):562-5; discussion 565-6. PubMed ID: 2238654
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
Nicolini A; Colombini C; Luciani L; Carpi A; Giuliani L
Br J Cancer; 1991 Jul; 64(1):154-8. PubMed ID: 1854615
[TBL] [Abstract][Full Text] [Related]
19. Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer.
Fernandes LC; Kim SB; Saad SS; Matos D
World J Gastroenterol; 2006 Jun; 12(24):3891-4. PubMed ID: 16804977
[TBL] [Abstract][Full Text] [Related]
20. Intensive risk-adjusted follow-up with the CEA, TPA, CA19.9, and CA72.4 tumor marker panel and abdominal ultrasonography to diagnose operable colorectal cancer recurrences: effect on survival.
Nicolini A; Ferrari P; Duffy MJ; Antonelli A; Rossi G; Metelli MR; Fulceri F; Anselmi L; Conte M; Berti P; Miccoli P
Arch Surg; 2010 Dec; 145(12):1177-83. PubMed ID: 21173292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
